Jane Street’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-12,046
Closed -$307K 10792
2021
Q1
$282K Buy
12,046
+1,561
+15% +$47.3K ﹤0.01% 7794
2020
Q4
$302K Sell
10,485
-16,648
-61% -$419K ﹤0.01% 6411
2020
Q3
$550K Buy
+27,133
New +$662K ﹤0.01% 5006

Jane Street's CNST Position: Q2 2021 in Review

Jane Street sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q2 2021, closing a stake of 12,046 shares — an estimated $307K sold.

Jane Street first reported a position in CNST in Q3 2020 and held it in 3 quarters. The position peaked at $550K in Q3 2020. 153 funds tracked by Wall St. Rank hold CNST as of Q2 2021.

  • Jane Street reported no remaining Constellation Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Jane Street sold 12,046 Constellation Pharmaceuticals, Inc. shares in Q2 2021, an estimated $307K.
  • Jane Street first reported a position in Constellation Pharmaceuticals, Inc. in Q3 2020 and held it in 3 quarters.
  • Jane Street's Constellation Pharmaceuticals, Inc. position peaked at $550K in Q3 2020.
  • 153 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q2 2021.

Based on Jane Street's 13F filing for Q2 2021, filed 16 Aug 2021.